- Review time: 84 days
- Recalls: 0
- Cited as a predicate by: 2 devices
The Cepheid Xpert® C. difficile Assay, performed on the Cepheid GeneXpert® Dx System, is a qualitative in vitro diagnostic test for rapid detection of toxin B gene sequences from unformed (liquid or soft) stool specimens collected from patients suspected of having Clostridium difficile infection (CDI).
- BD Geneohm Cdiff AssayK081920 · Bd Diagnostics (Geneohm Sciences, Inc.) · Dec 19, 2008
- Xpert C. Difficle/Epi AssayK110203 · Cepheid · Apr 7, 2011
- Illumigene C. Difficile, Illumipro-10 and Illumigene C. Difficile External Control Kit, Models 280050, 610172, 279920K100818 · Meridian Bioscience, Inc. · Jul 9, 2010
- SensiTox C. difficile Toxin TestK193490 · First Light Diagnostics, Inc. · Jul 8, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Apr 16, 2009
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.2660
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files